|
Model Number 145-5091-150 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/31/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned.¿ these words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that a echelon10 microcatheter marker band was damaged.During filling of the a1 aneurysm, it was found that the e10 distal mark fell to the a3 distal, so changed to use xt-17 for coil delivery.The catheter tip was not damaged.Surgical or medical intervention was not required.The devices were prepared as indicated in the instructions for use (ifu).The catheter was flushed as per ifu.The patient was undergoing aneurysm filled coil treatment.Vessel tortuosity was minimal.The access vessel was the femoral artery.No patient symptoms or complications were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Additional information received reported that after the e10 catheter marker fell to the distal end of a3.It was not removed, the surgeon considered that it fell in the distal blood vessel, and the incidence of occlusion complications was not high.However, if it was removed, the operation was complicated and might lead to a more serious risk of complications.Therefore, after weighing the advantages and disadvantages, it was not removed.The patient is currently in stable condition, and the long-term results are awaiting follow-up visit.
|
|
Manufacturer Narrative
|
H3: product analysis #280639632:¿ equipment used: vis (m-81805), 203cm ruler (m-83360) ¿drawing(s) referenced: dwgs145-5091-150 rev.Ar ¿as found condition: the echelon-10 micro catheter was returned for analysis within shipping box; within a plastic bio-pouch and within a dispenser coil.¿visual inspection/damage location details: upon visual inspection, no damages or irregularities were found with the echelon-10 catheter hub.The echelon-10 catheter body was found kinked at ~91.8cm from the hub.The echelon-10 distal marker/tip was found to be damaged/deformed.No other anomalies were observed.¿testing/analysis: the echelon-10 total and usable lengths were measured to be within specifications.The echelon-10 micro catheter was flushed, water exited from the distal tip.An in-house mandrel was inserted through the echelon-10 micro catheter without issue.¿conclusion based on the device analysis and reported information, the customer¿s report of ¿marker band dislodged¿ was confirmed.However, the root cause could not be determined.(nikkhs2 2022-09-24) medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|